# Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients

> **NCT00819325** · PHASE4 · COMPLETED · sponsor: **Queen Elizabeth II Health Sciences Centre** · enrollment: 50 (actual)

## Conditions studied

- Coronary Artery Disease
- Angina Pectoris
- Type 2 Diabetes Mellitus
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** pioglitazone
- **DRUG:** oral hypoglycemic agents

## Key facts

- **NCT ID:** NCT00819325
- **Lead sponsor:** Queen Elizabeth II Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2006-11
- **Final completion:** 2007-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2009-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00819325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00819325, "Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00819325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*